Radar · HealthTech in Cambridge
Best HealthTech Companies in Cambridge, United States
The 275 best HealthTech companies in Cambridge, United States in 2026, ranked by funding and momentum. Funding, investors, founders, valuation, tech stack and live signals. Top: XtalPi.
By Rohit KhannaTrends & Stories
275companies tracked
$6.3Bdisclosed funding
1unicorns
141have raised
FLIAR INTELLIGENCE · HEALTHTECH × CAMBRIDGE
Our analysis of 305 HealthTech companies
$32.1b in tracked funding; 95% of the stack-profiled cohort runs cloud-native; funding activity peaked in 2025.
305companies analysed
95%cloud-native stacks
2025funding peak (by rounds)
35unicorns
2018median founding year
599kcombined LinkedIn audience
38%of audience held by top 3
3companies hiring publicly (12 mo)
Ranked: Best HealthTech companies in Cambridge
| # | Company | Disclosed funding | Last round | Employees | Founder | Tech stack | Patents & IP focus | Recent signals |
|---|---|---|---|---|---|---|---|---|
| 1 | XtalPi 🦄 AI-based drug research and development company 64Funding top 18%AI top 26%Talent top 28%Patents top 31% All 13 signals ▾Fundingtop 18% AItop 26% Talenttop 28% Patentstop 31% Moattop 31% Innovationtop 34% Producttop 35% Newstop 38% Techtop 39% Growthtop 47% Globaltop 50% Marketbottom 43% Fin. healthbottom 32% Funding: Raised $785M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) AI: Classified as an AI company · Product described with: ai-based, machine learning rank vs industry peers · Fliar Intelligence Index 64/100 | $785M | 9 mo ago | 27 | — | WordPressMySQLPHP+28 | 14 patents Small-molecule STING agonists and PI3Kβ inhibitors for immuno‑oncology therapeutics | 1 partnership |
| 2 | Nimbus Therapeutics Developer of targeted therapeutics for cancer, metabolic and inflammatory diseases | $637M | 33 mo ago | 81 81 → 99 (+22%) · sector median +22% | Jeb Keiper CEO | WordPressApple iCloud MailMySQL+14 | — | — |
| 3 | Relay Therapeutics Developer of drug discovery platform and study protein motion | $520M | 29 mo ago | 245 245 → 218 (-11%) · sector median +22% | David Shaw Co-Founder | WordPressDrupalApple iCloud Mail+23 | 234 patents Small-molecule FGFR and PI3Kα kinase inhibitors for oncology applications | — |
| 4 | In Silico AI-enabled bioinformatics platform for drug discovery and biomarker development 82Funding top 15%Product top 19%AI top 20%News top 26% All 12 signals ▾Fundingtop 15% Producttop 19% AItop 20% Newstop 26% Partnerstop 26% Talenttop 28% Moattop 31% Innovationtop 35% Growthtop 35% Markettop 43% Techtop 46% Globalbottom 39% Funding: Raised $400M across 11 rounds · 11 rounds over 12 yrs (0.9/yr) Product: 3 distinct product lines · Company stage: Public rank vs industry peers · Fliar Intelligence Index 82/100 | $400M | 17 mo ago | 300 | Alex Zhavoronkov Co-Founder & Co-CEO | SentryMUIReact+10 | — | — |
| 5 | Cellarity AI-powered drug design and development platform | $294M | 44 mo ago | 117 117 → 72 (-38%) · sector median +22% | — | — | 26 patents AI-driven drug discovery and cellular diagnostic platforms using heterocyclic modulators | — |
| 6 | METiS Therapeutics Provider of an AI-assisted platform for drug discovery and development | $252M | 50 mo ago | 33 | Wenshou Wang Co-Founder | WixSentryBootstrap+9 | — | 1 partnership |
| 7 | Omega Therapeutics Provider of platform for human genome study for precision medicine | $211M | 62 mo ago | 93 | David Berry Co-Founder | DrupalPHPAmazon Web Services+20 | — | — |
| 8 | Iterative Health Provider of AI-based device for endoscopic images of gastroenterological diseases 78Growth top 13%Funding top 18%AI top 25%Moat top 31% All 7 signals ▾Growthtop 13% Fundingtop 18% AItop 25% Moattop 31% Techbottom 47% Marketbottom 44% Globalbottom 37% Growth: Headcount 22 → 75 (+241%) across vintages · Fresh capital in last 24 mo Funding: Raised $194M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) rank vs industry peers · Fliar Intelligence Index 78/100 | $194M | 1 mo ago | 75 75 → 177 (+136%) · sector median +22% | — | WordPressApple iCloud MailGoogle Workspace+22 | — | — |
| 9 | OM1 Platform that enables providers to manage CMS CJR bundle for value-based care | $171M | 59 mo ago | 141 141 → 100 (-29%) · sector median +22% | Richard Gliklich Founder & CEO | WordPressApple iCloud MailGoogle Workspace+25 | 19 patents Patient cohort classification and predictive analytics for personalized healthcare outcomes | 1 launch |
| 10 | PatientsLikeMe Provider of online information and patient's social network for discussing medical conditions | $151M | 64 mo ago | 43 43 → 32 (-26%) · sector median +22% | — | Apple iCloud MailMicrosoft 365Ruby+27 | 63 patents Patents concentrated in computing, sensing & instrumentation | — |
| 11 | Hydrow Provider of Rowing sports equipment for individuals | $142M | 42 mo ago | 134 134 → 107 (-20%) · sector median +22% | John Stellato CEO | Node.jsSalesforceRadix UI+13 | 69 patents Patents concentrated in health & consumer products | — |
| 12 | Harbinger Health AI-based cancer detection tool for providers 55Funding top 18%News top 36%Moat top 42%AI top 45% All 8 signals ▾Fundingtop 18% Newstop 36% Moattop 42% AItop 45% Talenttop 49% Techbottom 48% Marketbottom 43% Globalbottom 38% Funding: Raised $140M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) News: 2 BI events in 12 mo (of 13 tracked, 3 types) · Top themes: Leadership rank vs industry peers · Fliar Intelligence Index 55/100 | $140M | 2 mo ago | 60 | Stephen Hahn CEO | WordPressApple iCloud MailMySQL+23 | — | 2 launchs |
| 13 | Diagonal Therapeutics Developer of antibody therapeutics for the treatment of rare diseases 40Funding top 19%Moat top 42%Talent bottom 49%Market bottom 40% All 5 signals ▾Fundingtop 19% Moattop 42% Talentbottom 49% Marketbottom 40% Globalbottom 38% Funding: Raised $128M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Moat: Editorial + unicorn rating 5/10 · Soonicorn rank vs industry peers · Fliar Intelligence Index 40/100 | $128M | 5 mo ago | — | Alexey Lugovskoy CEO | — | — | — |
| 14 | Zageno Marketplace and life science research community for biotech research kits | $121M | 36 mo ago | 51 51 → 127 (+149%) · sector median +22% | Florian Wegener Co-Founder & CEO | HubSpot CMS HubApple iCloud MailGoogle Workspace+21 | — | 1 launch |
| 15 | Stipple Bio Provider of a platform that utilizes epitope-level resolution to unlock cellular profiling and target… 21Funding top 20%Talent top 38%Global bottom 48%Tech bottom 25% All 5 signals ▾Fundingtop 20% Talenttop 38% Globalbottom 48% Techbottom 25% Marketbottom 19% Funding: Raised $109M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 21/100 | $109M | 2 mo ago | 2 | Aaron Ring Co-Founder | WordPressMySQLPHP+11 | — | 1 partnership |
| 16 | Atavistik Developer of allosteric therapeutics for precision oncology and rare diseases 50Funding top 19%Talent top 28%Moat top 31%Market bottom 42% All 6 signals ▾Fundingtop 19% Talenttop 28% Moattop 31% Marketbottom 42% Globalbottom 36% Newsbottom 33% Funding: Raised $100M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 50/100 | $100M | 3 mo ago | 33 | Ralph DeBerardinis Co-Founder | — | — | — |
| 17 | Transition Bio Developer of a technology platform for the analysis of biomolecular condensate | $69M | 20 mo ago | 9 | David Weitz Co-Founder | WordPressMySQLPHP+13 | — | — |
| 18 | nference Provider of an AI platform for clinical data analysis and insights | $63M | 43 mo ago | 165 165 → 316 (+92%) · sector median +22% | Murali Aravamudan Co-Founder & CEO | PrismicNode.jsMUI+19 | 126 patents Patents concentrated in computing, sensing & instrumentation | — |
| 19 | Metaphore Provider of machine language and computational platform for drug discovery 42Funding top 23%Talent top 28%Moat top 42%AI top 45% All 7 signals ▾Fundingtop 23% Talenttop 28% Moattop 42% AItop 45% Globalbottom 36% Techbottom 35% Marketbottom 31% Funding: Raised $50.0M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 42/100 | $50M | 2 mo ago | 30 | Noubar Afeyan Co-Founder | WebflowMicrosoft 365jQuery+4 | — | — |
| 20 | Oncimmune Immunodiagnostics company developing biomarker platforms for cancer and immune diseases | $49M | 19 mo ago | 62 62 → 35 (-44%) · sector median +22% | Jamie Heywood Managing Director | WordPressMySQLPHP+21 | 4 patents Immunoassay development and calibration technologies for diagnostic testing | — |
| 21 | Legacy Provider of at-home sperm testing and storage services | $45M | 22 mo ago | 31 | Khaled Kteily Founder & CEO | Cart FunctionalityWebflowApple iCloud Mail+24 | 252 patents Medical interventional devices: self-adjusting catheters and clot retrieval systems | 1 award |
| 22 | Labviva Digital marketplace for life science products | $31M | 17 mo ago | 8 | Nicholas Rioux Co-Founder & CTO | — | — | 1 launch · 4 partnerships |
| 23 | 1910 Genetics Developer of small molecule therapeutics to treat pain and aging-related diseases | $30M | 19 mo ago | 18 | Jen Nwankwo Founder & CEO | — | — | — |
| 24 | Biobot Analytics Provider of tools to map microbes and chemicals of interest 53Growth top 26%Funding top 32%Moat top 41%Tech top 46% All 10 signals ▾Growthtop 26% Fundingtop 32% Moattop 41% Techtop 46% Talentbottom 49% Marketbottom 46% Patentsbottom 40% Innovationbottom 39% Globalbottom 37% Newsbottom 33% Growth: Headcount 38 → 98 (+158%) across vintages · Web rank 10,000,000 → 50,000,000 YoY Funding: Raised $29.2M across 5 rounds · 5 rounds over 8 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 53/100 | $29M | 12 mo ago | 98 | Mariana Matus Co-Founder & CEO | WordPress Block EditorWordPressApple iCloud Mail+27 | 4 patents Modular upstream wastewater sampling systems for population health surveillance | — |
| 25 | Luminopia Developer of VR-based solutions to treat visual disorders | $27M | 35 mo ago | 13 | Scott Xiao Co-Founder and CEO | WebflowSentryApple iCloud Mail+21 | 3 patents VR/AR head‑mounted systems for vision therapy and visual disorder treatment | 1 partnership |
| 26 | Cherish Health Developer of radar and AI-based technology for health and safety monitoring | $26M | 26 mo ago | 95 | Rosy Leo Chief Product Officer | Cart FunctionalitySquarespace CommerceSquarespace+16 | — | — |
| 27 | Nanopath Provider of point-of-care molecuolar diagnostic platform for womens health 72Innovation top 27%Funding top 29%Patents top 29%Moat top 32% All 6 signals ▾Innovationtop 27% Fundingtop 29% Patentstop 29% Moattop 32% Talentbottom 45% Globalbottom 31% Innovation: 38 patents (top 31% of patent-holders) · 25 filings since 2022 vs 13 in 2017-21 Funding: Raised $24.1M across 7 rounds · 7 rounds over 4 yrs (1.8/yr) rank vs industry peers · Fliar Intelligence Index 72/100 | $24M | 13 mo ago | — | Amogha Tadimety Co-Founder & Co-CEO | — | 38 patents Nanoplasmonic biosensor platforms for multiplexed pathogen and analyte detection | — |
| 28 | Xellar Developer of an AI-based computational platform for drug discovery | $24M | 23 mo ago | 12 | Xin Xie Co-Founder | — | 6 patents Patents concentrated in computing, sensing & instrumentation | — |
| 29 | Ketryx Provider of AI-native compliance software for regulated medical applications development 45Funding top 30%Tech top 40%AI top 45%Growth top 48% All 9 signals ▾Fundingtop 30% Techtop 40% AItop 45% Growthtop 48% Talentbottom 49% Moatbottom 48% Marketbottom 32% Newsbottom 31% Globalbottom 29% Funding: Raised $18.0M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) Tech: 36 technologies across 5/8 capability areas · Cloud: Amazon Web Services, Cloudflare rank vs industry peers · Fliar Intelligence Index 45/100 | $18M | 11 mo ago | 19 | Erez Kaminski CEO | WebflowSentryWistia+32 | — | — |
| 30 | Outcomes4Me App for medical health record for cancer | $16M | 12 mo ago | 20 20 → 33 (+65%) · sector median +22% | Maya Said Co-Founder & CEO | WordPress Block EditorElementorWordPress+34 | 9 patents Patents concentrated in computing, sensing & instrumentation | — |
| 31 | Rendever Provider of a virtual reality platform for elderly care 55Innovation top 23%Funding top 34%Growth top 35%Product top 48% All 8 signals ▾Innovationtop 23% Fundingtop 34% Growthtop 35% Producttop 48% Moattop 48% Techtop 50% Marketbottom 34% Globalbottom 29% Innovation: 4 product lines · Deep-tech classification: Tech Hardware Funding: Raised $15.1M across 8 rounds · 8 rounds over 9 yrs (0.9/yr) rank vs industry peers · Fliar Intelligence Index 55/100 | $15M | 7 mo ago | 24 24 → 34 (+42%) · sector median +22% | — | HubSpot CMS HubAmazon Web ServicesSplide+26 | — | 1 launch · 1 partnership |
| 32 | RISA Labs Provider of solutions for automating clinical operation 57Funding top 27%Talent top 28%Growth top 35%AI top 45% All 7 signals ▾Fundingtop 27% Talenttop 28% Growthtop 35% AItop 45% Techbottom 45% Marketbottom 35% Globalbottom 33% Funding: Raised $14.6M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) Talent: 3 named leaders on record · 3 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 57/100 | $15M | 5 mo ago | — | Kumar Shivang Co-Founder & CTO | WebflowGSAPSendgrid+13 | — | — |
| 33 | Seven Starling Online community platform for pregnancy and parenting 45Tech top 33%Funding top 35%Talent top 38%Growth top 40% All 7 signals ▾Techtop 33% Fundingtop 35% Talenttop 38% Growthtop 40% Newstop 48% Globalbottom 29% Marketbottom 28% Tech: 37 technologies across 5/8 capability areas · Cloud: Amazon Cloudfront, Amazon S3 Funding: Raised $13.8M across 3 rounds · 3 rounds over 5 yrs (0.6/yr) rank vs industry peers · Fliar Intelligence Index 45/100 | $14M | 9 mo ago | 21 | Tina Beilinson Co-Founder & CEO | WebflowSalesforceLever+18 | — | — |
| 34 | ExpressionEdits Provider of protein expression platform development services | $13M | 24 mo ago | 9 | Allan Bradley Co-Founder | Framer SitesVimeoReact+9 | — | — |
| 35 | HealthRhythms AI based mental health monitoring tool for healthcare providers | $12M | 16 mo ago | 42 | Tanzeem Choudhury Co-Founder & CTO | Webflow EcommerceWebflowYouTube+16 | — | — |
| 36 | Epicore Biosystems Developer of sweat-sensing wearables for real-time health monitoring 50Talent top 30%News top 34%Funding top 35%Moat top 37% All 10 signals ▾Talenttop 30% Newstop 34% Fundingtop 35% Moattop 37% Innovationtop 42% Patentstop 44% Producttop 46% Techtop 49% Marketbottom 40% Globalbottom 36% Talent: 4 named leaders on record · 4 C-suite/founder profiles curated News: 3 BI events in 12 mo (of 5 tracked, 3 types) · +200% YoY rank vs industry peers · Fliar Intelligence Index 50/100 | $12M | 13 mo ago | 23 | Stephen Lee Co-Founder & CTO | Node.jsSalesforceChakra UI+16 | 19 patents Wearable sweat‑analysis fluidic devices for real‑time biofluid composition monitoring | 1 launch |
| 37 | Synthpop AI-powered clinical management software 62Growth top 28%News top 32%Funding top 37%Talent top 38% All 9 signals ▾Growthtop 28% Newstop 32% Fundingtop 37% Talenttop 38% Techtop 42% AItop 45% Moattop 48% Marketbottom 36% Globalbottom 36% Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo News: 3 BI events in 12 mo (of 7 tracked, 1 types) · Top themes: Funding rank vs industry peers · Fliar Intelligence Index 62/100 | $11M | 10 mo ago | — | Jan Jannink Co-Founder & CTO | Webflowstyled-componentsReact+15 | — | — |
| 38 | Genomate Health AI-based computational system cancer treatment decisions | $10M | 15 mo ago | 4 | Ioana Stupariu Co-Founder | WebflowCart FunctionalityPlyr+21 | — | — |
| 39 | Dimagi Open source mobile software for health workers | $10M | 14 mo ago | 50 | Vikram Sheel Kumar Co-Founder & Chairman | WordPressSentryApple iCloud Mail+31 | — | 1 partnership |
| 40 | Origin Medical AI powered platform to support prenatal care with an evaluation of pregnancy | $7M | 10 mo ago | — | Sripad Devalla Co-Founder & CEO | WebflowMicrosoft ClarityGoogle Analytics+14 | — | — |
| 41 | Folia Provider of a platform for health tracking of children 53Tech top 25%Growth top 28%Talent top 34%Funding top 38% All 10 signals ▾Techtop 25% Growthtop 28% Talenttop 34% Fundingtop 38% Producttop 40% Moattop 47% Innovationbottom 43% Globalbottom 31% Marketbottom 30% Patentsbottom 26% Tech: 44 technologies across 6/8 capability areas · Cloud: Cloudflare Growth: Web rank 10,000,000 → 5,000,000 YoY · Fresh capital in last 24 mo rank vs industry peers · Fliar Intelligence Index 53/100 | $6M | 8 mo ago | 20 | Nell Luo Founder & CEO | Squarespace CommerceCart FunctionalitySquarespace+29 | 2 patents Bio-based polymer synthesis and polysuccinimide derivative manufacturing | — |
| 42 | DynamiCare Health Provider of digital therapeutics for substance use recovery | $5M | 21 mo ago | 26 | Kelley Bowker CEO | Squarespace CommerceSquarespaceApple iCloud Mail+34 | — | — |
| 43 | Stata DX Provider of liquid MRI-based platform for neurological diseases 11Funding top 46%Talent bottom 49%Global bottom 30%Market bottom 24% All 4 signals ▾Fundingtop 46% Talentbottom 49% Globalbottom 30% Marketbottom 24% Funding: Raised $4.5M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) Talent: 1 named leader on record · 1 C-suite/founder profile curated rank vs industry peers · Fliar Intelligence Index 11/100 | $4M | 3 mo ago | 10 | Michal Depa Co-Founder | — | — | — |
| 44 | QSimulate Laboratory focused on developing of quantitative simulation tools to help in quantum molecular 32Growth top 35%Talent top 38%Funding top 41%Moat top 48% All 7 signals ▾Growthtop 35% Talenttop 38% Fundingtop 41% Moattop 48% Techbottom 36% Globalbottom 36% Marketbottom 24% Growth: Fresh capital in last 24 mo Talent: 2 named leaders on record · 2 C-suite/founder profiles curated rank vs industry peers · Fliar Intelligence Index 32/100 | $4M | 6 mo ago | 14 14 → 21 (+50%) · sector median +22% | Toru Shiozaki Co-Founder & CEO | UbuntuYouTubeBootstrap+6 | — | 1 job opening |
| 45 | Layer Health AI-powered clinical documentation management software for hospitals | $4M | 17 mo ago | — | Divya Gopinath Co-founder & Co-Head of Engineering | Framer SitesApple iCloud MailGoogle Workspace+9 | — | — |
| 46 | Korus Provider of smart mattresses and software for sleep management 37Funding top 44%Talent bottom 45%Product bottom 36%Global bottom 29% All 4 signals ▾Fundingtop 44% Talentbottom 45% Productbottom 36% Globalbottom 29% Funding: Raised $2.6M across 1 rounds · 1 rounds over 1 yrs (1.0/yr) Talent: 1 named leader on record rank vs industry peers · Fliar Intelligence Index 37/100 | $3M | 10 mo ago | — | Andres Rodriguez Camelo Co-Founder & Co-CEO | — | — | — |
| 47 | Ceretype Provider of brain circuit profiles and actionable brain biomarker solutions | $2M | 14 mo ago | 3 | Emily Stern Co-Founder & CEO | — | — | — |
| 48 | Dynocardia.Care Provider of wearable devices for remote monitoring solutions | $2M | 13 mo ago | 12 | — | Cart FunctionalitySquarespace CommerceSquarespace+10 | — | — |
| 49 | Florey Biosciences Developer of engineered probiotics for gut microbiome health | $1M | 14 mo ago | — | Andres Ruiz Co-Founder & Chief Executive Officer | — | — | — |
| 50 | Accure Health Provider of precision medicine solutions for oncology patients | $800K | 9 mo ago | 4 | Hakho lee Founder | — | — | — |
Top 12 HealthTech companies in Cambridge
#1
Series C · Cambridge, Massachusetts · founded 2017 · 75 employees$193.5Mraised▾
Series C · Cambridge, Massachusetts · founded 2017 · 75 employees
Provider of AI-based device for endoscopic images of gastroenterological diseases. The platform interprets endoscopic pictures and other forms of data using machine learning and computer vision, allowing clinicians to better diagnose patients with possible GI disorders. "SKOUT" is a polyp detection system that employs artificial intelligence to assist gastroenterologists in detecting more adenomas during colonoscopy.
Fliar Intelligence Index™ 78how this company ranks against its industry peers
Growth
top 13%Funding
top 18%AI
top 25%Moat
top 31%Tech
bottom 47%Market
bottom 44%Growth: Headcount 22 → 75 (+241%) across vintages · Fresh capital in last 24 mo
Funding: Raised $194M across 4 rounds · 4 rounds over 6 yrs (0.7/yr) · Last round Series C (May 2026)
AI: Product described with: ai-based, artificial intelligence, computer vision
Audience (LinkedIn): 28k LinkedIn followers — 4.6% of this cohort's audience
Funding rounds
- May 2026Series C$77M
- Jan 2022Series B$150M
- Aug 2021Series A$30M
- Jan 2020Seed$13.5M
Investors
Tau Ventures, P5 Health Ventures, Wavemaker 360, Micron, Time BioVentures, Valor Capital Group
Tech stack
Apple Icloud MailBricksCloudflareCloudflare Bot ManagementCloudflare Browser InsightsCore-Js
#2
Series B · Cambridge, Massachusetts · founded 2008 · 60 employees$140Mraised▾
Series B · Cambridge, Massachusetts · founded 2008 · 60 employees
AI-based cancer detection tool for providers. The company has developed a blood test detection tool that enables professionals to analyze and detect early cancers.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Funding
top 18%News
top 36%Moat
top 42%AI
top 45%Talent
top 49%Tech
bottom 48%Funding: Raised $140M across 3 rounds · 3 rounds over 3 yrs (1.0/yr) · Last round Series B (Apr 2026)
News: 2 BI events in 12 mo (of 13 tracked, 3 types) · Top themes: Leadership
Moat: Editorial + unicorn rating 4/10 · Soonicorn · 10 curated direct competitors tracked
Audience (LinkedIn): 8k LinkedIn followers
Activity (LinkedIn): 2 product launches announced in 12 mo
Funding rounds
- Apr 2026Series B$100M
- Sep 2023Series B$140M
- 2021Series A$50M
Founders & team
Investors
Flagship Pioneering, Pictet Group, Partners Investment, Venture Catalysts, M&G, Camillus LifeSciences
Tech stack
Apple Icloud MailCloudflareCloudflare Bot ManagementCore-JsGoogle AnalyticsGoogle Font Api
#3
XtalPi 🦄Public · Cambridge, Massachusetts · founded 2014 · 27 employees$784.8Mraised▾
XtalPi 🦄
Public · Cambridge, Massachusetts · founded 2014 · 27 employees
XtalPi has developed a proprietary technology FACES(Fast Accurate Crystalline Engineering System), which is a cloud-based computing system to predict the crystal structure which will identify polymorphs of the compound. The company's algorithms are integrated with the Amazon Web Service (AWS) high-performance computing (HPC) resources in the cloud. The team claims to have a strong background in quantum physics and machine learning. It provides services to pharmaceutical companies at various stages of drug development. The company has deployed its technology to develop an Intelligent Digital Drug Discovery and Development (ID4) platform to improve the efficiency, accuracy, and success rate of drug discovery.
Fliar Intelligence Index™ 64how this company ranks against its industry peers
Funding
top 18%AI
top 26%Talent
top 28%Patents
top 31%Moat
top 31%Innovation
top 34%Funding: Raised $785M across 8 rounds · 8 rounds over 11 yrs (0.7/yr) · Last round Post IPO (Sep 2025)
AI: Classified as an AI company · Product described with: ai-based, machine learning
Talent: Analyst team rating 4/5
Audience (LinkedIn): 18k LinkedIn followers — 2.9% of this cohort's audience
Activity (LinkedIn): 1 partnerships (incl. OpenEye, Cadence Molecular Sciences) announced in 12 mo
Funding rounds
- Sep 2025Post IPO$268M
- Feb 2025Post IPO$268.4M
- Aug 2021Series D$400M
- Sep 2020Series C$318.8M
Investors
Tencent, Frees Fund, Zhen Fund, Renren, SoftBank Vision Fund, People's Insurance Company of China
Tech stack
Animate.CssBootstrapCdnjsCloudflareCloudflare Bot ManagementCore-Js
#4
Series A · Cambridge, Massachusetts · founded 2021 · 2 employees$109.5Mraised▾
Series A · Cambridge, Massachusetts · founded 2021 · 2 employees
Provider of a platform that utilizes epitope-level resolution to unlock cellular profiling and target discovery. The platform technology enables single-cell profiling and target identification for ddrug discovery and development of cancer immunotherapy and others.
Fliar Intelligence Index™ 21how this company ranks against its industry peers
Funding
top 20%Talent
top 38%Global
bottom 48%Tech
bottom 25%Market
bottom 19%Funding: Raised $109M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series A (Mar 2026)
Talent: 2 named leaders on record · 2 C-suite/founder profiles curated
Global: Investors from 1 country beyond United States
Audience (LinkedIn): 4k LinkedIn followers
Activity (LinkedIn): 1 partnerships (incl. Lonza) announced in 12 mo
Funding rounds
- Mar 2026Series A$100M
- Dec 2024Series A$9.5M
Founders & team
Investors
RA Capital Management, Andreessen Horowitz, Nextech Invest, Emerson Collective, Google Ventures, GordonMD Global Investments
Tech stack
AstraCore-JsElementorGoogle Font ApiGoogle Hosted LibrariesJquery
#5
Series B · Cambridge, Massachusetts · founded 2021 · 33 employees$100Mraised▾
Series B · Cambridge, Massachusetts · founded 2021 · 33 employees
Developer of allosteric therapeutics for precision oncology and rare diseases. The company integrated with proprietary drug discovery platform that enables to unlock novel allosteric binding pockets and rapidly advance structural insights into small molecule therapeutics designt to unlock cryptic allosteric sites across a broad range of target classes.
Fliar Intelligence Index™ 50how this company ranks against its industry peers
Funding
top 19%Talent
top 28%Moat
top 31%Market
bottom 42%Global
bottom 36%News
bottom 33%Funding: Raised $100M across 4 rounds · 4 rounds over 5 yrs (0.8/yr) · Last round Series B (Mar 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 8/10 · Soonicorn · 10 curated direct competitors tracked
Audience (LinkedIn): 4k LinkedIn followers
Funding rounds
- Mar 2026Series B$40M
- Dec 2025Series B$120M
- Dec 2023Series A$40M
- Aug 2021Series A$60M
Founders & team
Investors
The Column Group, Lux Capital, Nextech Invest, Regeneron Ventures, RA Capital Management
#6
Series B · Cambridge, Massachusetts · founded 2022$128Mraised▾
Series B · Cambridge, Massachusetts · founded 2022
Developer of antibody therapeutics for the treatment of rare diseases. The company's DIAGONAL platform combines proprietary computational and experimental techniques to develop agonist antibody therapies for hereditary hemorrhagic telangiectasia and pulmonary arterial hypertension.
Fliar Intelligence Index™ 40how this company ranks against its industry peers
Funding
top 19%Moat
top 42%Talent
bottom 49%Market
bottom 40%Global
bottom 38%Funding: Raised $128M across 2 rounds · 2 rounds over 2 yrs (1.0/yr) · Last round Series B (Jan 2026)
Moat: Editorial + unicorn rating 5/10 · Soonicorn · 10 curated direct competitors tracked
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Audience (LinkedIn): 6k LinkedIn followers
Funding rounds
- Jan 2026Series B$125M
- Apr 2024Series A$128M
Founders & team
Investors
VF Partners, Atlas Venture, CHECKPOINT, Frazier Life Sciences, Lightspeed Venture Partners, RA Capital Management
#7
Series C · Cambridge, Massachusetts · founded 2021 · 30 employees$50Mraised▾
Series C · Cambridge, Massachusetts · founded 2021 · 30 employees
Provider of machine language and computational platform for drug discovery. The company uses biomimicry and machine learning to unleash the transformational medicinal potential of functional molecular mimics. The MIMiC platform, developed by the company is a computationally driven bioplatform for developing novel therapies in which function, specificity, and selectivity may be optimized.
Fliar Intelligence Index™ 42how this company ranks against its industry peers
Funding
top 23%Talent
top 28%Moat
top 42%AI
top 45%Global
bottom 36%Tech
bottom 35%Funding: Raised $50.0M across 1 rounds · 1 rounds over 3 yrs (0.3/yr) · Last round Series C (Apr 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Moat: Editorial + unicorn rating 4/10 · Soonicorn · 9 curated direct competitors tracked
Audience (LinkedIn): 5k LinkedIn followers
Funding rounds
- Apr 2026Series C—
- May 2023Series C$50M
Founders & team
Investors
Flagship Pioneering, TOHO HOLDINGS
Tech stack
CloudflareHstsHttp/3JqueryMicrosoft 365Webflow
#8
Public · Cambridge, Massachusetts · founded 2014 · 300 employees$399.8Mraised▾
Public · Cambridge, Massachusetts · founded 2014 · 300 employees
AI-enabled bioinformatics platform for drug discovery and biomarker development. The company provides solutions and services such as custom drug discovery engines, biomarker discovery, and aging research tools to academia, pharmaceutical, and cosmetics companies. Also, it has developed a product PHARMA.AI which includes modules for drug discovery such as PandaOmics, Chemistry42, and InClinico.
Fliar Intelligence Index™ 82how this company ranks against its industry peers
Funding
top 15%Product
top 19%AI
top 20%News
top 26%Partners
top 26%Talent
top 28%Funding: Raised $400M across 11 rounds · 11 rounds over 12 yrs (0.9/yr) · Last round Series E (Jan 2025)
Product: 3 distinct product lines · Company stage: Public
AI: Classified as an AI company
Audience (LinkedIn): 88k LinkedIn followers — 14.6% of this cohort's audience
Funding rounds
- Jan 2025Series E$110M
- Aug 2022Series D$35M
- Jun 2022Series D$60M
- Jun 2021Series C$255M
Founders & team
Investors
Prosperity7 Ventures, Qiming Venture Partners, BHR, Warburg Pincus, Bold Capital Partners, Pavilion Capital Partners
Tech stack
Amazon SesAmazon Web ServicesDdos-GuardEmotionGoogle AnalyticsGoogle Font Api
#9
Series A · Cambridge, Massachusetts · founded 2024$14.6Mraised▾
Series A · Cambridge, Massachusetts · founded 2024
Provider of solutions for automating clinical operation. Platform leveraging artificial intelligence to streamline healthcare processes, particularly in the area of prior authorization for oncology treatments. Platform calculates patient financial responsibilities based on various codes requiring prior authorization. Platform provides real-time assessments of whether prior authorization is necessary for procedures or medications.
Fliar Intelligence Index™ 57how this company ranks against its industry peers
Funding
top 27%Talent
top 28%Growth
top 35%AI
top 45%Tech
bottom 45%Market
bottom 35%Funding: Raised $14.6M across 2 rounds · 2 rounds over 1 yrs (2.0/yr) · Last round Series A (Jan 2026)
Talent: 3 named leaders on record · 3 C-suite/founder profiles curated
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 20k LinkedIn followers — 3.4% of this cohort's audience
Funding rounds
- Jan 2026Series A$11.1M
- Apr 2025Seed$3.5M
Founders & team
Investors
Oncology Ventures, General Catalyst, Z21 Ventures, Odd Bird, Cencora, Optum Ventures
Tech stack
CloudflareCloudflare Bot ManagementGoogle AnalyticsGoogle Font ApiGoogle Hosted LibrariesGoogle Tag Manager
#10
Funding Raised · Cambridge, Massachusetts · founded 2015 · 24 employees$15.1Mraised▾
Funding Raised · Cambridge, Massachusetts · founded 2015 · 24 employees
Provider of a virtual reality platform for elderly care. Develops software that runs on VR headsets like Samsung Gear VR. Features include immersive experiences to stimulate brain function, a variety of programs to engage diverse personal interests, guided tours for shared experiences. Target customers are elder care communities and home help agencies, with a subscription fee for hardware and software components, as well as maintenance.
Fliar Intelligence Index™ 55how this company ranks against its industry peers
Innovation
top 23%Funding
top 34%Growth
top 35%Product
top 48%Moat
top 48%Tech
top 50%Innovation: 4 product lines · Deep-tech classification: Tech Hardware
Funding: Raised $15.1M across 8 rounds · 8 rounds over 9 yrs (0.9/yr) · Last round Grant (prize money) (Nov 2025)
Growth: Fresh capital in last 24 mo
Audience (LinkedIn): 14k LinkedIn followers — 2.3% of this cohort's audience
Activity (LinkedIn): 1 product launches · 1 partnerships (incl. Nicholas Pure Solutions) announced in 12 mo
Funding rounds
- Nov 2025Grant (prize money)$4.5M
- Sep 2025Grant (prize money)$1.4M
- Apr 2025Grant (prize money)$349.3K
- Mar 2025Grant (prize money)$2.2M
Investors
MassChallenge, NIH, HHS, The Company Lab, TiE ScaleUp, Dorm Room Fund
Tech stack
AdrollAdroll Cmp SystemAmazon S3Amazon Web ServicesCloudflareCloudflare Bot Management
#11
Seed · Cambridge, Massachusetts · founded 2022 · 10 employees$4.5Mraised▾
Seed · Cambridge, Massachusetts · founded 2022 · 10 employees
Provider of liquid MRI-based platform for neurological diseases. It offers an affinity-based electrochemical sensing platform that detects biomarkers in biological fluids. It aids in immunoassays, enzymatic assays, and nucleic acid detection.
Fliar Intelligence Index™ 11how this company ranks against its industry peers
Funding
top 46%Talent
bottom 49%Global
bottom 30%Market
bottom 24%Funding: Raised $4.5M across 3 rounds · 3 rounds over 4 yrs (0.8/yr) · Last round Seed (Feb 2026)
Talent: 1 named leader on record · 1 C-suite/founder profile curated
Global: Single-market focus (United States)
Audience (LinkedIn): 744 LinkedIn followers
Funding rounds
- Feb 2026Seed$1.9M
- Mar 2024Seed$1.8M
- Jan 2022Seed$2.7M
Founders & team
#12
Series A · Cambridge, Massachusetts · founded 2017 · 98 employees$29.2Mraised▾
Series A · Cambridge, Massachusetts · founded 2017 · 98 employees
Provider of tools to map microbes and chemicals of interest. The collected samples are tested for pathogens and chemicals of interest using patent bioassays and robotics and the data obtained is analyzed for trends and insights into human health. They call this collection of data a Human health Observatory.
Fliar Intelligence Index™ 53how this company ranks against its industry peers
Growth
top 26%Funding
top 32%Moat
top 41%Tech
top 46%Talent
bottom 49%Market
bottom 46%Growth: Headcount 38 → 98 (+158%) across vintages · Web rank 10,000,000 → 50,000,000 YoY · Fresh capital in last 24 mo
Funding: Raised $29.2M across 5 rounds · 5 rounds over 8 yrs (0.6/yr) · Last round Series A (May 2025)
Moat: Editorial + unicorn rating 7/10 · IP moat: 4 patents · 9 curated direct competitors tracked
Audience (LinkedIn): 9k LinkedIn followers
Funding rounds
- May 2025Series A$13.5M
- Oct 2021Series A$20M
- Apr 2020Seed$6.7M
- Apr 2020Grant (prize money)$1.5M
Founders & team
Investors
Engine, American Family Insurance Institute for Corporate and Social Impact, Y Combinator, DCVC, Thursday Ventures, Plum Alley Investments
Tech stack
Amazon Web ServicesApple Icloud MailBootstrapCdnjsCloudflareContact Form 7
Funding & investor landscape
$6.3Btotal disclosed funding
144companies funded
453disclosed rounds
4rounds last 90 days
Most active investors
Y Combinator6 rounds
Techstars5 rounds
Notable founders
Stephen Hahn
CEO · Harbinger Health
Aaron Ring
Co-Founder · Stipple Bio
Aashish Manglik
Co-Founder · Stipple Bio
Ralph DeBerardinis
Co-Founder · Atavistik
Jared Rutter
Co-Founder · Atavistik
Alexey Lugovskoy
CEO · Diagonal Therapeutics
Noubar Afeyan
Co-Founder · Metaphore
Lovisa Afzelius
Co-Founder & CEO · Metaphore
Alex Zhavoronkov
Co-Founder & Co-CEO · In Silico
Stephanie Williams
Co-Founder · In Silico
Kumar Shivang
Co-Founder & CTO · RISA Labs
Rishabh Sahu
Co-Founder · RISA Labs
Prism market signals · United States · country-scoped Prism corpus, 2,619,476 docs
Market landscape — 10 sub-themes by coverage
Share of HealthTech coverage by sub-theme.
Regulatory-risk over time rising
Funding & growth over time
funding rising · growth rising
RESEARCH IN CAMBRIDGE · Health & Bio
How research on Digital Health in Cambridge is moving
A read on the academic research around Digital Health in Cambridge — which themes are gaining ground, the institutions and researchers driving them, and how the tone is shifting. Based on 113 papers.
University of Cambridge and NHS trusts dominate Cambridge's digital-health research, focusing on AI, telehealth, and digital mental health, with a cautiously contested tone (mean stance 0.15, concerns outweighing breakthroughs).
113 papers · stance +0.15 · 14% breakthrough · 52% concern
top institutions
- University of Cambridge87
- Cambridge University Hospitals NHS Foundation Trust14
- Cambridgeshire and Peterborough NHS Foundation Trust5
- Cambridge University Press4
- Cambridge School4
leading researchers
Charlton, Peter H · Coca-Castro, Alejandro · Fouilloux, Anne · Hyde, Andrew · McDonald, Andrew · Erin L. Funnell
prism intelligence · tone & topics
85% positive · 10% critical tone
HealthcareMental HealthGovernmentBusinessPolicyData Science
▲
Breakthroughs14 · 12%
▼ 20%→12% share
▼0.6× share momentum0 median citations86% since 2021mostly methods-led
Remote patient monitoring research newly emerged with 4 papers, driving Breakthroughs share down from 20% to 12%.
rising sub-themes (early→recent)
- Remote patient monitoring4
- Photoplethysmogram3
- Usability3
- Psychological intervention3
- Health informatics3
Newly emergingRemote patient monitoring 0→4 · Photoplethysmogram 0→3 · Usability 0→3
Landmark IDEAS (Integrate, Design, Assess, and Share): A Framework and Toolkit of Strategies for the Development of More Effectiv · 409 cites
◆
Advancements34 · 30%
▲ 20%→29% share
▲1.4× share momentum0 median citations85% since 2021mostly methods-led
Advancements intensifying — Health care, Psychological intervention, and Health informatics all brand-new, lifting field-share from 20% to 29%.
rising sub-themes (early→recent)
- Health care10
- Health informatics7
- Psychological intervention6
- Wearable computer5
- Public health4
Newly emergingHealth care 0→9 · Psychological intervention 0→6 · Health informatics 0→6
Landmark Materials Informatics with PoreBlazer v4.0 and the CSD MOF Database · 318 cites
▼
Concerns53 · 47%
▲ 40%→49% share
▲1.2× share momentum0 median citations92% since 2021mostly empirical
Health informatics concerns rose 1→7 papers; Wearable computer newly entered with 10, pushing Concerns share from 40% to 49%.
rising sub-themes (early→recent)
- Health informatics1→7
- Public health1→6
- Qualitative research1→3
Newly emergingHealth care 0→12 · Wearable computer 0→10 · Wearable technology 0→6
Landmark Digital health: meeting the ethical and policy challenges · 185 cites
Common questions
How many HealthTech companies are there in Cambridge, United States?
Radar tracks 275 indexable HealthTech companies headquartered in Cambridge, United States that meet our profile-completeness bar.
What is the total funding raised by HealthTech companies in Cambridge, United States?
The HealthTech companies in Cambridge, United States on this list have raised a combined $6.3B in disclosed equity funding across 144 funded companies.
Which is the highest-funded HealthTech company in Cambridge, United States?
XtalPi is the highest-funded HealthTech company in Cambridge, United States, with $784.8M in disclosed equity funding.
How many HealthTech companies in Cambridge, United States are funded?
144 of the 275 HealthTech companies in Cambridge, United States on this list have disclosed at least one equity funding round.
How many HealthTech unicorns are there in Cambridge, United States?
1 HealthTech company in Cambridge, United States on this list is valued at $1B or more.
Who are the top investors in Cambridge, United States HealthTech companies?
The most active investors in Cambridge, United States HealthTech companies on this list include HHS, MassChallenge, Flagship Pioneering, MIT Alumni Angels of Boston, General Catalyst.
Rohit KhannaTrends & Stories
Rohit lives in the feed. He covers what's moving right now — the funding rounds, launches and shifts breaking across the trade press — and ties them back to where the sector is heading.